MARINA KONOPLEVA to Staurosporine
This is a "connection" page, showing publications MARINA KONOPLEVA has written about Staurosporine.
Connection Strength
0.061
-
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome. Am J Hematol. 2015 Apr; 90(4):276-81.
Score: 0.030
-
Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors. Cancer Res. 2006 Feb 15; 66(4):2367-75.
Score: 0.016
-
Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis. J Cell Physiol. 2004 Aug; 200(2):223-34.
Score: 0.015